13F-HR filed by Rubric Capital Management LP
Rubric Capital Management LP filed this 13F-HR for the quarter ended 2023-12-31, filed 2024-02-13, with 58 holding rows worth $4,819,423,759.
- Accession
- 0001104659-24-019871
- Filer
- CIK 1687509
- Filed
- 2024-02-13
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2023
A holdings report, 58 entries on the cover page, a total value of $4,819,423,759 stated on the cover page (in dollars after the unit check, H1), rows summing to $4,819,423,759 with VALUE read as dollars as filed, 13F file number 028-17624. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| SPY | 78462F103 | SHS | 4,500,000 | $2,138,895,000 | dollars as filed | put |
| ROIVANT SCIENCES LTD | G76279101 | SHS | 19,000,000 | $213,370,000 | dollars as filed | |
| TEVA PHARMACEUTICAL INDS LTD SPONSORED ADS | 881624209 | ADR | 18,226,601 | $190,285,714 | dollars as filed | |
| VIATRIS INC COM | 92556V106 | Stock | 17,567,892 | $190,260,270 | dollars as filed | |
| GOLAR LNG LTD | G9456A100 | SHS | 6,506,757 | $149,590,343 | dollars as filed | |
| BGC GROUP INC CL A | 088929104 | Stock | 20,000,000 | $144,400,000 | dollars as filed | |
| MR COOPER GROUP INC | 62482R107 | COM | 1,785,795 | $116,290,970 | dollars as filed | |
| COLLEGIUM PHARMACEUTICAL INC | 19459J104 | COM | 2,758,253 | $84,899,027 | dollars as filed | |
| RENEW ENERGY GLOBAL PLC CL A SHS | G7500M104 | Stock | 10,420,000 | $79,817,200 | dollars as filed | |
| QUIDELORTHO CORP COM | 219798105 | Stock | 980,063 | $72,230,643 | dollars as filed | |
| PACTIV EVERGREEN INC | 69526K105 | COM | 5,039,766 | $69,095,192 | dollars as filed | |
| ANI PHARMACEUTICALS INC | 00182C103 | COM | 1,125,000 | $62,032,500 | dollars as filed | |
| NCR VOYIX CORPORATION | 62886E108 | COM | 3,591,228 | $60,727,665 | dollars as filed | |
| STRATASYS LTD | M85548101 | SHS | 4,250,000 | $60,690,000 | dollars as filed | |
| FLUOR CORP | 343412102 | COM | 1,510,172 | $59,153,437 | dollars as filed | |
| CONSTELLIUM SE | F21107101 | CL A SHS | 2,924,438 | $58,371,782 | dollars as filed | |
| ADEIA INC | 00676P107 | COM | 4,640,009 | $57,489,712 | dollars as filed | |
| AAR CORP | 000361105 | COM | 895,904 | $55,904,410 | dollars as filed | |
| DOLE PLC | G27907107 | ORD SHS | 4,530,940 | $55,685,253 | dollars as filed | |
| LIBERTY GLOBAL LTD | G61188101 | COM CL A | 2,979,328 | $52,942,659 | dollars as filed | |
| KOPPERS HOLDINGS INC | 50060P106 | COM | 1,007,341 | $51,596,006 | dollars as filed | |
| KINIKSA PHARMACEUTICALS LTD | G5269C101 | COM CL A | 2,907,501 | $50,997,568 | dollars as filed | |
| ORTHOFIX MED INC | 68752M108 | COM | 3,665,000 | $49,404,200 | dollars as filed | |
| AMNEAL PHARMACEUTICALS INC | 03168L105 | COM STK CL A | 8,000,000 | $48,560,000 | dollars as filed | |
| HERON THERAPEUTICS INC | 427746102 | COM | 26,713,503 | $45,412,955 | dollars as filed | |
| PAR PAC HOLDINGS INC | 69888T207 | COM NEW | 1,199,749 | $43,634,871 | dollars as filed | |
| TRANSALTA CORP | 89346D107 | COM | 5,145,630 | $42,760,185 | dollars as filed | |
| SCHWEITZER-MAUDUIT INTL INC | 808541106 | COM | 2,682,400 | $41,067,544 | dollars as filed | |
| GOODRX HLDGS INC | 38246G108 | COM CL A | 5,872,806 | $39,347,800 | dollars as filed | |
| PLAYA HOTELS & RESORTS NV | N70544106 | SHS | 4,431,161 | $38,329,543 | dollars as filed | |
| ZYMEWORKS INC | 98985Y108 | COM | 3,475,384 | $36,109,240 | dollars as filed | |
| LIBERTY GLOBAL LTD | G61188127 | COM CL C | 1,852,856 | $34,537,236 | dollars as filed | |
| MEREO BIOPHARMA GROUP PLC | 589492107 | CMN | 13,552,997 | $31,307,423 | dollars as filed | |
| XPERI INC | 98423J101 | COMMON STOCK | 2,555,632 | $28,163,065 | dollars as filed | |
| ARDELYX INC | 039697107 | COM | 4,012,753 | $24,879,069 | dollars as filed | |
| SCPHARMACEUTICALS INC | 810648105 | COM | 3,500,000 | $21,945,000 | dollars as filed | |
| ARCUTIS BIOTHERAPEUTICS INC | 03969K108 | COM | 6,644,530 | $21,461,832 | dollars as filed | |
| RISKIFIED LTD A | M8216R109 | COMMON STOCK | 4,173,636 | $19,532,616 | dollars as filed | |
| OMNIAB INC | 68218J103 | COM | 2,850,588 | $17,588,128 | dollars as filed | |
| SILK ROAD MEDICAL INC | 82710M100 | COMMON STOCK | 1,427,905 | $17,520,394 | dollars as filed | |
| OVID THERAPEUTICS INC | 690469101 | COMMON STOCK | 5,315,969 | $17,117,420 | dollars as filed | |
| PACIRA BIOSCIENCES INC COM | 695127100 | Stock | 491,322 | $16,577,204 | dollars as filed | |
| SUTRO BIOPHARMA INC | 869367102 | COM | 3,344,810 | $14,349,235 | dollars as filed | |
| ADAPTIVE BIOTECHNOLOGIES CORP COM | 00650F109 | Stock | 2,862,729 | $14,027,372 | dollars as filed | |
| REVANCE THERAPEUTICS INC | 761330109 | COM | 1,461,474 | $12,846,356 | dollars as filed | |
| FTAI INFRASTRUCTURE INC | 35953C106 | COMMON STOCK | 3,193,530 | $12,422,832 | dollars as filed | |
| TELESAT CORP | 879512309 | CL A & CL B SHS | 959,764 | $10,010,339 | dollars as filed | |
| TREVI THERAPEUTICS INC COM | 89532M101 | Stock | 5,684,420 | $7,617,123 | dollars as filed | |
| WEREWOLF THERAPEUTICS INC | 95075A107 | CMN | 1,935,357 | $7,470,478 | dollars as filed | |
| Cannae Holdings, Inc. | 13765N107 | Common Stock, $0.0001 par value | 362,961 | $7,081,369 | dollars as filed | |
| CULLINAN THERAPEUTICS INC | 230031106 | COM | 626,929 | $6,388,407 | dollars as filed | |
| PLAYSTUDIOS INC | 72815G108 | CLASS A COM | 1,961,184 | $5,314,809 | dollars as filed | |
| BICYCLE THERAPEUTICS PLC-ADR | 088786108 | SPONSORED ADS | 205,423 | $3,714,048 | dollars as filed | |
| ARS PHARMACEUTICALS INC | 82835W108 | COM | 639,203 | $3,502,832 | dollars as filed | |
| THERAPEUTICSMD INC | 88338N206 | COM NEW | 1,192,191 | $2,682,430 | dollars as filed | |
| COHERUS ONCOLOGY INC | 19249H103 | COM | 395,207 | $1,316,039 | dollars as filed | |
| VINCERX PHARMA INC | 92731L106 | COM NEW | 354,377 | $418,165 | dollars as filed | |
| COHERUS BIOSCIENCES INC | 19249HAB9 | BOND | 500,000 | $280,849 | dollars as filed | principal |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001104659-24-019871 | this filing | 2024-02-13 | acceptance time not in the bulk data set |